Profile
ALIM TAK ZTS HLN TEVA VTRS
Company Name Alimera Sciences, Inc. Takeda Pharmaceutical Company Limited Zoetis Inc. Haleon plc Teva Pharmaceutical Industries Limited Viatris Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic
Market Cap $301.29M $58.03B $55.37B $49.48B $38.97B $18.16B
Employees 0.15K 49.28K 13.80K 24.56K 37.00K 32.00K
CEO Richard S. Eiswirth Jr. Christophe Weber Kristin C. Peck Brian James McNamara Richard D. Francis Scott Andrew Smith
Ratings
ALIM TAK ZTS HLN TEVA VTRS
Quant Rating Score 1 3 3 4 3 2
Quant Rating Strong Sell Neutral Neutral Buy Neutral Sell
Trading
ALIM TAK ZTS HLN TEVA VTRS
Last Close $5.54 $14.14 $118.8 $9.68 $24.59 $10.66
High 52 $5.54 $15.52 $178.71 $11.41 $25.83 $13.37
Low 52 $5.54 $12.89 $118.8 $8.73 $12.82 $7.26
Price vs. 52 Week High 0 % -8.89 % -33.52 % -15.16 % -4.8 % -20.27 %
Price vs. 52 Week Low 0 % 9.7 % 0 % 10.88 % 91.81 % 46.83 %
Total Return
ALIM TAK ZTS HLN TEVA VTRS
1 Month Return 0 % 0.71 % -17.53 % 2.11 % 27.34 % 4.82 %
3 Month Return 0 % -6.73 % -21.96 % -0.05 % 36.16 % 0.28 %
6 Month Return 0 % 0.21 % -27.13 % -10.37 % 45.16 % 20.59 %
9 Month Return 0 % 1.73 % -24.08 % -3.1 % 48.4 % -1.84 %
YTD Return 0 % 6.8 % -27.09 % 1.47 % 11.57 % -14.38 %
1 Year Return 0 % 3.82 % -32.33 % 2.11 % 46.28 % -18.31 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ALIM TAK ZTS HLN TEVA VTRS
Dividend Yield Percentage (TTM) - 3.53 % 1.62 % 1.41 % - 3.04 %
Dividend Paid and Capex Coverage Ration (TTM) -0.19 % 2.23 % 1.89 % 2.01 % 4 % 2.09 %
Dividend Per Share (TTM) - 198 % 2.03 % 0.06 % - 0.48 %
Payout Ratio (TTM) -6.25 % 277.04 % 32.55 % 27.27 % - -15.34 %
Growth
ALIM TAK ZTS HLN TEVA VTRS
Asset Growth 260.37 % -0.34 % 0.76 % 3.61 % -12.97 %
Gross Profit Growth 32.54 % 9.63 % -0.19 % 10.86 % -12.66 %
Revenue Growth 49.19 % 8.33 % -0.61 % 4.32 % -4.46 %
Revenue 3 Year -68.18 % 24.31 % 19.01 % 11.71 % -16.52 %
Revenue 5 Year -60.54 % 55.65 % 33.95 % -1.27 % -39.86 %
Revenue 10 Year 255.23 % 113.39 % 33.95 % -34.65 % -36.45 %
EBIT Growth 19.15 % 5.67 % 13.52 % -9.52 % -109.43 %
Net Income Growth -11.18 % 6.06 % 37.46 % 185.97 % -1259.41 %
Net Income 3 Yeari Growth Per Share 24.5 % 27.46 % 4.91 % 155.65 % 49.38 %
Net Income 5 Yeari Growth Per Share 71.79 % 74.46 % 122.63 % 133.65 % -1871.56 %
Net Income 10 Yeari Growth Per Share 96.41 % 370.4 % 122.63 % -33.98 % -122.71 %
Operating Income Growth 83.4 % 10.52 % 10.52 % 1131.35 % -98.68 %
Operating Cash Flow Growth (CFG) -42.97 % 25.5 % 9.57 % -35.33 % -17.74 %
Operating 3 Year CFG -30.2 % 39.36 % 71.6 % 0.19 % -22.68 %
Operating 5 Year CFG 71.67 % 73.18 % 196.04 % 29.24 % -40.08 %
Operating 10 Year CFG 96.89 % 420.39 % 196.04 % -77.86 % -24.47 %
EPS Growth 69.5 % 7.68 % 33.33 % 184.83 % -1262.28 %
EPS Diluted Growth 69.5 % 7.89 % 33.33 % 182.76 % -1269.98 %
Book Value Per Share 160.62 % -2.96 % -1.63 % 36.19 % -8.42 %
Share Holder 3 Year Equity Growth Per Share 215.87 % 9.65 % -37.97 % -2.08 % -7.88 %
Share Holder 5 Year Equity Growth Per Share 289.31 % 85.42 % -40.16 % -24.81 % -26.41 %
Share Holder 10 Year Equity Growth Per Share 177.2 % 301.38 % -40.16 % -80.23 % 90.51 %
Dividend Per Share Growth - 15.33 % 49.01 % - 0.45 %
Dividend 3 Year Growth Per Share - 73.18 % -49.79 % - 45.93 %
Dividend 5 Year Growth Per Share - 163.51 % -49.97 % - -
Dividend 10 Year Growth Per Share - 493.89 % -49.97 % -100 % -
Debt Growth 52.04 % -0.16 % 6.83 % -3.86 % -22.13 %
Free Cash Flow Growth -777.74 % 41.76 % 16.27 % -43.99 % -14.98 %
Updated On 31 Dec 2023 31 Dec 2024 31 Dec 2024 31 Dec 2025 31 Dec 2024
Profitability
ALIM TAK ZTS HLN TEVA VTRS
Gross Profit Margin TTM 75.75 % 59.49 % 70.63 % 61.81 % 51.76 % 36.07 %
Return on Assets TTM -13.11 % 0.73 % 17.49 % 4.78 % 3.48 % -9.73 %
Return on Equity TTM -159.01 % 1.58 % 53.56 % 9.4 % 20.09 % -22.69 %
Return on Capital Employed TTM -1.47 % 3.59 % 26.48 % 8.34 % 11.54 % -8.43 %
Net Income Per EBT TTM 100.42 % 54.99 % 79.59 % 76.52 % 114.62 % 95.92 %
EBT Per Ebit TTM 1037.63 % 44.75 % 94.2 % 88.09 % 39.3 % 149.32 %
EBIT Per Revenue TTM -2.39 % 10.28 % 37.63 % 20.49 % 18.15 % -18.25 %
Cash Flow To Debt Ratio TTM -21.16 % 23.13 % 40.09 % 12.02 % 11.62 % 13.47 %
Receivables Turnover TTM 2.34 5.89 6.1 5.14 4.68 3.94
Payables Turnover TTM 2.37 3.87 6.73 1.18 3.31 6.81
Inventory Turnover TTM 10.42 1.29 1.12 3.72 2.63 2.2
Fixed Asset Turnover TTM 2249.42 % 214.23 % 241.44 % 589.57 % 392.13 % 488.38 %
Asset Turnover TTM 52.6 % 28.97 % 61.99 % 34.62 % 42.58 % 37.25 %
Operating Cash Flow Per Share TTM -0.56 710.55 6.58 0.11 1.76 1.7
Free Cash Flow Per Share TTM -3.51 589.53 5.06 0.1 1.32 1.37
Cash Per Share TTM 47.3 % 48236.45 % 470.54 % 7.46 % 309.55 % 99.36 %
Operating Cash Flow Sales Ratio TTM -17.66 % 25.14 % 31.03 % 9.32 % 11.64 % 14.04 %
Free Cash Flow Operating Cash Flow Ratio TTM 629.64 % 82.97 % 76.82 % 90.65 % 74.99 % 80.65 %
Cash Flow Coverage Ratios TTM -21.16 % 23.13 % 40.09 % 12.02 % 11.62 % 13.47 %
Price To Free Cash Flows Ratio TTM -3.36 9.52 24.72 38.08 25.61 11.36
Price To Operating Cash Flows Ratio TTM -9.93 7.9 19.08 35.1 19.24 9.26
Price Cash Flow Ratio TTM -9.93 7.9 19.08 35.1 19.24 9.26
Income Statement (TTM)
ALIM TAK ZTS HLN TEVA VTRS
Revenue $0.08B $4581.55B $9.47B $11.23B $17.26B $14.74B
Gross Profit $0.06B $3001.33B $0B $6.95B $8.94B $5.62B
Gross Profit Ratio 75.75% 65.51% 0% 61.85% 51.79% 38.15%
EBITDA $-0B $1210.51B $0B $2.51B $3.14B $2.82B
Net Income $-0.02B $107.93B $2.67B $1.44B $1.41B $-0.63B
EPS Diluted -0.79 33.62 6.02 0.32 1.2 -0.53
Balance Sheet (MRQ)
ALIM TAK ZTS HLN TEVA VTRS
Long Term Debt $0.06B $3966.33B $0.2B $8.62B $15.56B $14.22B
Total Liabilities $0.11B $7312.37B $12.14B $18.09B $32.83B $22.87B
Total Equity $0.05B $6935.98B $3.33B $16.22B $7.91B $18.64B
Total Investments $0B $382.4B $0B $0.14B $0B $1.7B
Total Debt $0.07B $4515.27B $0.2B $10.1B $17.38B $14.31B
Total Assets $0.15B $14248.34B $15.47B $34.32B $40.75B $41.5B
Cash Flow Statement (TTM)
ALIM TAK ZTS HLN TEVA VTRS
Net Income $-0.02B $107.93B $2.67B $1.44B $1.42B $-0.63B
Inventory $-0B $-34.97B $-0.2B $0.22B $0.15B $-0.72B
Dividends Paid $-0B $-302.5B $-0.89B $-0.57B $0B $-0.57B
Operating Cash Flow $-0.01B $1057.18B $2.9B $2.3B $1.65B $2.3B
Capital Expenditure $-0.08B $-200.8B $-0.62B $-0.25B $-0.5B $-0.33B
Related Stocks
Ticker Name Price
ACB Aurora Cannabis Inc. 3.55
ACOR Acorda Therapeutics, Inc. 0.661
ACRX AcelRx Pharmaceuticals, Inc. 0.86
ADMP Adamis Pharmaceuticals Corporation 0.775
ADMS Adamas Pharmaceuticals, Inc. 8.22
AERI Aerie Pharmaceuticals, Inc. 15.25
AGRX Agile Therapeutics, Inc. 1.51
AKAN Akanda Corp. 0.8964
ALVO Alvotech 4.64
ALVOW Alvotech 0.3025
AMPH Amphastar Pharmaceuticals, Inc. 28.5
AMRX Amneal Pharmaceuticals, Inc. 14.82
AMYT Amryt Pharma plc 14.7
ANIP ANI Pharmaceuticals, Inc. 77.36
APUS Apimeds Pharmaceuticals US, Inc 1.23
AQST Aquestive Therapeutics, Inc. 3.65
ASRT Assertio Holdings, Inc. 12.375
ATNX Athenex, Inc. 0.2031
AVDL Avadel Pharmaceuticals plc 21.64
AYTU Aytu BioPharma, Inc. 2.13
ETFs With Exposure to ALIM
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0.00462 262.96
VTI Vanguard Total Stock Market Index Fund 0 336.65
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 149.23
IWN iShares Russell 2000 Value ETF 0.00105 199.97
IWO iShares Russell 2000 Growth ETF 0.00841 334.76
VXF Vanguard Extended Market Index Fund 0 216.28
HDG ProShares Hedge Replication ETF 0.000735944 52.7
UWM ProShares Ultra Russell2000 0.00175936 53.08
VTHR Vanguard Russell 3000 Index Fund 0 301.597
IWC iShares Micro-Cap ETF 0.03229 166.03
URTY ProShares UltraPro Russell2000 0.000866593 63.07
VTWV Vanguard Russell 2000 Value Index Fund 0 176.213
VTWG Vanguard Russell 2000 Growth Index Fund 0.01 244.5
VTWO Vanguard Russell 2000 Index Fund 0 106.26
DFUS Dimensional U.S. Equity ETF 0 74.35
DFAC Dimensional U.S. Core Equity 2 ETF 0 40.79
VTSAX Vanguard Total Stock Market Index Fund 0 163.89
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 164.01
VITSX Vanguard Total Stock Market Index Fund 0 163.92
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 164.02
VEMPX Vanguard Extended Market Index InstlPlus 0 404.75
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 307.49
RSSL Global X Funds 0.01 102.97
Unlock